ClinicalTrials.Veeva

Menu

The Role of Hydrosalpinx in Recurrent Miscarriage

U

University of Birmingham

Status

Completed

Conditions

Hydrosalpinx
Abortion, Spontaneous
Miscarriage, Recurrent

Treatments

Diagnostic Test: Hysterosalpingo-contrast-sonogram

Study type

Observational

Funder types

Other

Identifiers

NCT03703401
IRAS ID 232650

Details and patient eligibility

About

Miscarriage affects one in five pregnancies and little progress has been made in understanding and treating this distressing condition. C. trachomatis is the most common sexually transmitted infection in the UK. C. trachomatis infection can have serious health consequences, including fallopian tube damage. Untreated C. trachomatis infection and tubal damage have been associated with miscarriage and adverse pregnancy outcomes such as preterm birth, low birth weight and stillbirth. A cohort study is needed to establish the prevalence of tubal disease in women with recurrent miscarriages. HyCoSy will be performed to identify tubal disease and establish the magnitude of the problem in the recurrent miscarriage population. The prognosis of tubal disease on miscarriage and other obstetric outcomes, and the role of medical interventions such as tubal surgery (to treat hydrosalpinx) on reducing miscarriage and adverse obstetric outcomes will also be studied.

Objectives

  1. Establish the prevalence of hydrosalpinx in the recurrent miscarriage population.
  2. Establish the prognosis of women diagnosed with recurrent miscarriage with concurrent hydrosalpinx.
  3. Explore the role of tubal surgery for improving reproductive outcomes in women with recurrent miscarriage population and hydrosalpinx.

Enrollment

137 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-45
  • Women diagnosed with recurrent miscarriage i.e. 2 or more miscarriages
  • Ability to give informed consent

Exclusion criteria

  • Allergy to contrast media used for Hysterosalpingo-contrast-sonogram
  • Allergy to sonographic gel used for ultrasound scanning
  • Anatomical anomaly meaning transvaginal ultrasound scan not possible
  • Stenosed/occluded cervix meaning contrast media unable to be introduced via cervix
  • Inability to give informed consent
  • Pregnant at the time of recruitment
  • Declined recruitment

Trial design

137 participants in 3 patient groups

Women with recurrent miscarriage and no hydrosalpinx
Treatment:
Diagnostic Test: Hysterosalpingo-contrast-sonogram
Women with recurrent miscarriage and concurrent hydrosalpinx
Treatment:
Diagnostic Test: Hysterosalpingo-contrast-sonogram
Women with recurrent miscarriage and treated hydrosalpinx
Treatment:
Diagnostic Test: Hysterosalpingo-contrast-sonogram

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems